| 2026 |
| 11/17 | (IR情報)15:30 2027年3月期第2四半期決算説明会資料 |
| 11/17 | 118 | 118 | 113 | 115 | -4.17% | 180,100 | - | -16.06% |
| 11/16 | 124 | 124 | 118 | 120 | -4.76% | 209,600 | - | -13.04% |
| 11/13 | (IR情報)15:30 営業外収益、営業外費用及び特別損失の計上に関するお知らせ |
| 11/13 | (IR情報)15:30 2027年3月期第2四半期(中間期)決算短信〔日本基準〕(非連結) |
| 11/13 | 123 | 129 | 123 | 126 | +0.8% | 153,600 | - | -9.35% |
| 11/12 | 126 | 128 | 124 | 125 | -2.34% | 88,900 | - | -11.35% |
| 11/11 | (IR情報)13:00 湧永製薬株式会社が「川崎病治療選択補助PTX3定性キット」の 体外診断用医薬品製造販売承認を取得 |
| 11/11 | 125 | 133 | 123 | 128 | +1.59% | 240,500 | - | -9.86% |
| 11/10 | 123 | 126 | 120 | 126 | +2.44% | 204,700 | - | -12.5% |
| 11/10 | (空売り報告)Barclays Capital Securities Ltd 165,100株(0.89%)-0.09% |
| 11/09 | 120 | 125 | 120 | 123 | +4.24% | 139,500 | - | -15.17% |
| 11/09 | (空売り報告)Barclays Capital Securities Ltd 182,000株(0.98%)-0.02% |
| 11/06 | 124 | 129 | 115 | 118 | -11.94% | 595,800 | - | -19.73% |
| 11/06 | (空売り報告)JPM Securities Japan Co Ltd. 153,100株(0.83%)+0.18% |
| 11/06 | (空売り報告)Barclays Capital Securities Ltd 185,800株(1%)+0.05% |
| 11/05 | (IR情報)15:30 第68回米国血液学会(ASH)年次総会における PPMX-T003の臨床研究結果の発表採択のお知らせ |
| 11/05 | 136 | 143 | 132 | 134 | -0.74% | 287,400 | - | -10.07% |
| 11/05 | (空売り報告)JPM Securities Japan Co Ltd. 120,300株(0.65%)+0.15% |
| 11/05 | (空売り報告)Barclays Capital Securities Ltd 175,400株(0.95%)+0.1% |
| 11/04 | 136 | 137 | 130 | 135 | -0.74% | 331,900 | - | -10% |
| 11/04 | (空売り報告)JPM Securities Japan Co Ltd. 92,400株(0.5%)再IN |
| 11/04 | (空売り報告)Nomura International plc 75,761株(0.41%)-0.11%義務消失 |
| 11/04 | (空売り報告)Barclays Capital Securities Ltd 158,200株(0.85%)-0.09% |
| 11/02 | 139 | 140 | 136 | 136 | -4.23% | 200,900 | - | -9.93% |
| 11/02 | (空売り報告)Nomura International plc 96,723株(0.52%)-0.09% |
| 11/02 | (空売り報告)Barclays Capital Securities Ltd 173,500株(0.94%)+0.15% |
| 10/30 | 142 | 147 | 139 | 142 | +1.43% | 248,300 | - | -7.19% |
| 10/30 | (空売り報告)Nomura International plc 113,675株(0.61%)再IN |
| 10/29 | (IR情報)16:00 PPMXと杏林製薬、新規抗体医薬創出を目指し共同研究契約を締結 |
| 10/29 | 144 | 144 | 139 | 140 | -3.45% | 109,600 | - | -9.09% |
| 10/28 | 139 | 146 | 139 | 145 | +5.84% | 195,800 | - | -7.05% |
| 10/27 | 138 | 140 | 136 | 137 | -0.72% | 124,500 | - | -12.74% |
| 10/26 | 136 | 139 | 135 | 138 | 0% | 154,300 | - | -13.21% |
| 10/23 | 141 | 141 | 133 | 138 | -4.17% | 353,500 | - | -13.75% |
| 10/22 | 146 | 148 | 142 | 144 | -2.04% | 166,000 | - | -11.11% |
| 10/21 | 146 | 149 | 146 | 147 | +2.08% | 126,600 | - | -9.26% |
| 10/21 | (空売り報告)Barclays Capital Securities Ltd 146,500株(0.79%)-0.09% |
| 10/20 | 150 | 152 | 144 | 144 | -3.36% | 234,700 | - | -11.66% |
| 10/19 | 149 | 152 | 147 | 149 | -1.32% | 93,000 | - | -9.15% |
| 10/19 | (空売り報告)Barclays Capital Securities Ltd 163,600株(0.88%)-0.06% |
| 10/16 | 148 | 152 | 148 | 151 | +2.03% | 79,700 | - | -7.93% |
| 10/15 | 151 | 151 | 146 | 148 | -2.63% | 209,700 | - | -9.76% |
| 10/15 | (空売り報告)Barclays Capital Securities Ltd 173,300株(0.94%)-0.1% |
| 10/14 | 153 | 153 | 151 | 152 | -1.3% | 72,500 | - | -7.32% |
| 10/13 | 153 | 156 | 152 | 154 | +0.65% | 105,700 | - | -5.52% |
| 10/09 | 150 | 155 | 150 | 153 | +2% | 97,200 | - | -6.13% |
| 10/08 | 155 | 156 | 150 | 150 | -4.46% | 268,900 | - | -7.98% |
| 10/08 | (空売り報告)Barclays Capital Securities Ltd 192,000株(1.04%)+0.06% |
| 10/07 | 164 | 164 | 155 | 157 | -4.27% | 279,900 | - | -3.09% |
| 10/07 | (空売り報告)Barclays Capital Securities Ltd 182,400株(0.98%)+0.11% |
| 10/07 | (空売り報告)GOLDMAN SACHS INTERNATIONAL 80,366株(0.43%)-0.15%義務消失 |
| 10/06 | 167 | 170 | 164 | 164 | -1.2% | 136,600 | - | +1.23% |
| 10/06 | (空売り報告)Barclays Capital Securities Ltd 161,900株(0.87%)-0.04% |
| 10/05 | 162 | 168 | 162 | 166 | +3.11% | 229,000 | - | +3.11% |
| 10/05 | (空売り報告)GOLDMAN SACHS INTERNATIONAL 107,166株(0.58%)-0.1% |
| 10/02 | 163 | 164 | 160 | 161 | -3.01% | 135,400 | - | 0% |
| 10/02 | (空売り報告)Barclays Capital Securities Ltd 169,100株(0.91%)+0.08% |
| 10/01 | (IR情報)10:00 BioJapan2026出展のお知らせ |
| 10/01 | 165 | 166 | 161 | 166 | -0.6% | 130,000 | - | +3.75% |
| 10/01 | (空売り報告)GOLDMAN SACHS INTERNATIONAL 126,066株(0.68%)-0.11% |
| 09/30 | 168 | 169 | 163 | 167 | +1.83% | 176,500 | - | +4.38% |
| 09/30 | (空売り報告)Nomura International plc 61,195株(0.33%)再IN |
| 09/29 | 174 | 174 | 163 | 164 | -4.09% | 233,900 | - | +3.14% |
| 09/29 | (空売り報告)GOLDMAN SACHS INTERNATIONAL 145,766株(0.79%)-0.02% |
| 09/28 | 171 | 174 | 170 | 171 | 0% | 165,400 | - | +8.23% |
| 09/28 | (空売り報告)GOLDMAN SACHS INTERNATIONAL 150,966株(0.81%)+0.04% |
| 09/25 | 175 | 175 | 168 | 171 | -2.29% | 330,100 | - | +8.92% |
| 09/25 | (空売り報告)GOLDMAN SACHS INTERNATIONAL 143,666株(0.77%)-0.11% |
| 09/24 | 180 | 180 | 172 | 175 | -3.85% | 454,600 | - | +12.18% |
| 09/24 | (空売り報告)GOLDMAN SACHS INTERNATIONAL 163,266株(0.88%)-0.09% |
| 09/18 | 184 | 193 | 180 | 182 | -2.15% | 783,600 | - | +17.42% |
| 09/18 | (空売り報告)Nomura International plc 64,475株(0.34%)-0.4%義務消失 |
| 09/18 | (空売り報告)Barclays Capital Securities Ltd 153,900株(0.83%)-0.18% |
| 09/18 | (空売り報告)GOLDMAN SACHS INTERNATIONAL 178,966株(0.97%)+0.22% |
| 09/17 | 182 | 189 | 178 | 186 | +3.33% | 684,700 | - | +21.57% |
| 09/17 | (空売り報告)Nomura International plc 136,688株(0.74%)-0.44% |
| 09/17 | (空売り報告)Barclays Capital Securities Ltd 187,000株(1.01%)-0.11% |
| 09/17 | (空売り報告)GOLDMAN SACHS INTERNATIONAL 138,866株(0.75%)再IN |
| 09/16 | 176 | 182 | 173 | 180 | +5.26% | 642,600 | - | +18.42% |
| 09/16 | (空売り報告)Barclays Capital Securities Ltd 207,100株(1.12%)-0.09% |
| 09/15 | 168 | 175 | 167 | 171 | +0.59% | 530,700 | - | +14% |
| 09/15 | (空売り報告)Barclays Capital Securities Ltd 223,900株(1.21%)-0.09% |
| 09/14 | (IR情報)15:30 第5回日本抗体学会学術大会における発表採択のお知らせ |
| 09/14 | 164 | 172 | 163 | 170 | +4.29% | 1,031,600 | - | +14.09% |
| 09/14 | (空売り報告)Nomura International plc 217,573株(1.18%)-0.19% |
| 09/14 | (空売り報告)Barclays Capital Securities Ltd 240,400株(1.3%)+0.13% |
| 09/11 | 156 | 164 | 155 | 163 | +1.88% | 386,200 | - | +10.14% |
| 09/11 | (空売り報告)Barclays Capital Securities Ltd 217,000株(1.17%)-0.09% |
| 09/10 | 154 | 161 | 154 | 160 | +0.63% | 593,800 | - | +8.84% |
| 09/10 | (空売り報告)Nomura International plc 253,898株(1.37%)-0.14% |
| 09/10 | (空売り報告)Barclays Capital Securities Ltd 232,600株(1.26%)-0.27% |
| 09/09 | 158 | 163 | 154 | 159 | -2.45% | 1,189,300 | - | +8.9% |
| 09/09 | (空売り報告)MERRILL LYNCH INTERNATIONAL 65,200株(0.35%)-0.16%義務消失 |
| 09/09 | (空売り報告)Barclays Capital Securities Ltd 283,300株(1.53%)+0.46% |
| 09/08 | (IR情報)11:00 当社の研究用試薬「抗MMAE抗体」を用いたSLC46A3による薬物運搬機能の解明結果に関する東京薬科大学との共著論文公開のお知らせ |
| 09/08 | 148 | 194 | 145 | 163 | +10.14% | 12,927,100 | - | +11.64% |
| 09/08 | (空売り報告)Nomura International plc 278,366株(1.51%)再IN |
| 09/08 | (空売り報告)MERRILL LYNCH INTERNATIONAL 94,900株(0.51%)再IN |
| 09/08 | (空売り報告)Barclays Capital Securities Ltd 198,200株(1.07%)-0.38% |
| 09/07 | 144 | 148 | 143 | 148 | +2.07% | 130,400 | - | +2.07% |
| 09/04 | 141 | 145 | 141 | 145 | +2.84% | 129,900 | - | +0.69% |
| 09/04 | (空売り報告)Barclays Capital Securities Ltd 267,800株(1.45%)-0.06% |
| 09/03 | 141 | 143 | 141 | 141 | -0.7% | 93,400 | - | -2.08% |
| 09/03 | (空売り報告)Barclays Capital Securities Ltd 279,600株(1.51%)+0.03% |
| 09/02 | 141 | 145 | 140 | 142 | -1.39% | 197,600 | - | -1.39% |
| 09/02 | (空売り報告)Barclays Capital Securities Ltd 274,300株(1.48%)+0.1% |
| 09/01 | 144 | 144 | 142 | 144 | 0% | 166,600 | - | -0.69% |
| 09/01 | (空売り報告)Barclays Capital Securities Ltd 254,700株(1.38%)-0.1% |
| 08/31 | (IR情報)15:30 個人株主向け日本橋ラボ見学会 開催のお知らせ |
| 08/31 | 149 | 149 | 143 | 144 | -3.36% | 222,400 | - | -0.69% |
| 08/28 | 149 | 150 | 146 | 149 | 0% | 130,300 | - | +2.76% |
| 08/28 | (空売り報告)Barclays Capital Securities Ltd 274,000株(1.48%)-0.07% |
| 08/27 | 150 | 151 | 149 | 149 | -0.67% | 117,400 | - | +2.76% |
| 08/26 | 148 | 152 | 147 | 150 | +2.04% | 200,200 | - | +3.45% |
| 08/25 | (IR情報)11:00 TOKYO戦略的イノベーション促進事業の完了のお知らせ |
| 08/25 | 146 | 147 | 143 | 147 | -0.68% | 170,800 | - | +1.38% |
| 08/24 | 147 | 150 | 146 | 148 | +0.68% | 121,600 | - | +2.07% |
| 08/21 | (IR情報)11:00 PPMX-T003:大腸がん転移に対するトランスフェリン受容体1抗体の前臨床研究に関する 論文発表のお知らせ |
| 08/21 | 147 | 148 | 144 | 147 | -0.68% | 245,900 | - | +1.38% |
| 08/21 | (空売り報告)Barclays Capital Securities Ltd 285,900株(1.55%)-0.11% |
| 08/20 | (IR情報)13:00 日本証券新聞社主催<東京>【バイオ IR Day】の動画公開のお知らせ |
| 08/20 | 142 | 148 | 142 | 148 | +4.96% | 162,400 | - | +1.37% |
| 08/20 | (空売り報告)Barclays Capital Securities Ltd 306,100株(1.66%)-0.22% |
| 08/19 | 144 | 144 | 140 | 141 | -2.76% | 152,600 | - | -3.42% |
| 08/19 | (空売り報告)Barclays Capital Securities Ltd 346,700株(1.88%)+0.15% |
| 08/18 | 145 | 147 | 144 | 145 | 0% | 154,200 | - | -0.68% |
| 08/18 | (空売り報告)Barclays Capital Securities Ltd 320,600株(1.73%)-0.07% |
| 08/17 | 146 | 146 | 140 | 145 | 0% | 189,600 | - | -1.36% |
| 08/17 | (空売り報告)Barclays Capital Securities Ltd 333,000株(1.8%)-0.22% |
| 08/14 | 144 | 147 | 141 | 145 | -1.36% | 164,000 | - | -1.36% |
| 08/14 | (空売り報告)Nomura International plc 76,996株(0.41%)-0.14%義務消失 |
| 08/14 | (空売り報告)Barclays Capital Securities Ltd 372,500株(2.02%)-0.1% |
| 08/13 | (IR情報)15:30 2027年3月期第1四半期決算短信〔日本基準〕(非連結) |
| 08/13 | (IR情報)15:30 営業外収益、営業外費用及び特別損失の計上に関するお知らせ |
| 08/13 | 144 | 149 | 144 | 147 | +2.8% | 259,400 | - | 0% |
| 08/13 | (空売り報告)Barclays Capital Securities Ltd 391,600株(2.12%)-0.15% |
| 08/12 | 142 | 145 | 141 | 143 | +0.7% | 98,800 | - | -3.38% |
| 08/12 | (空売り報告)Nomura International plc 101,879株(0.55%)-0.09% |
| 08/12 | (空売り報告)Barclays Capital Securities Ltd 419,700株(2.27%)-0.06% |
| 08/10 | 144 | 145 | 139 | 142 | 0% | 143,500 | - | -4.05% |
| 08/10 | (空売り報告)Nomura International plc 119,452株(0.64%)-0.07% |
| 08/10 | (空売り報告)Barclays Capital Securities Ltd 430,700株(2.33%)-0.11% |
| 08/07 | 141 | 142 | 140 | 142 | +0.71% | 125,800 | - | -4.7% |
| 08/07 | (空売り報告)Nomura International plc 132,028株(0.71%)+0.04% |
| 08/06 | 143 | 143 | 140 | 141 | -0.7% | 99,300 | - | -5.37% |
| 08/06 | (空売り報告)Nomura International plc 123,678株(0.67%)-0.11% |
| 08/05 | 144 | 145 | 141 | 142 | 0% | 134,200 | - | -5.33% |
| 08/05 | (空売り報告)Barclays Capital Securities Ltd 451,300株(2.44%)-0.13% |
| 08/04 | 139 | 143 | 138 | 142 | +2.9% | 137,200 | - | -5.96% |
| 08/04 | (空売り報告)Barclays Capital Securities Ltd 474,200株(2.57%)-0.16% |
| 08/03 | (IR情報)15:30 Eurus社との新たな共同研究契約締結のお知らせ |
| 08/03 | 144 | 144 | 134 | 138 | -4.83% | 443,400 | - | -9.21% |
| 08/03 | (空売り報告)Nomura International plc 144,248株(0.78%)+0.17% |
| 08/03 | (空売り報告)Barclays Capital Securities Ltd 504,700株(2.73%)+0.04% |
| 07/31 | (IR情報)15:30 第85回日本癌学会学術総会における発表採択のお知らせ |
| 07/31 | 145 | 148 | 144 | 145 | +1.4% | 204,800 | - | -5.23% |
| 07/31 | (空売り報告)Nomura International plc 114,105株(0.61%)-0.17% |
| 07/31 | (空売り報告)Barclays Capital Securities Ltd 497,000株(2.69%)-0.27% |
| 07/30 | 144 | 145 | 142 | 143 | +0.7% | 122,000 | - | -7.14% |
| 07/30 | (空売り報告)Nomura International plc 145,196株(0.78%)-0.11% |
| 07/30 | (空売り報告)Barclays Capital Securities Ltd 545,600株(2.96%)-0.05% |
| 07/29 | (IR情報)15:30 研究用試薬「抗S100A4タンパク質抗体」発売のお知らせ |
| 07/29 | 143 | 144 | 142 | 142 | -2.07% | 190,500 | - | -7.79% |
| 07/29 | (空売り報告)Nomura International plc 164,056株(0.89%)-0.04% |
| 07/28 | 150 | 150 | 143 | 145 | -2.68% | 271,100 | - | -6.45% |
| 07/28 | (空売り報告)Barclays Capital Securities Ltd 555,700株(3.01%)+0.16% |
| 07/27 | 144 | 151 | 144 | 149 | +4.2% | 274,200 | - | -3.87% |
| 07/27 | (空売り報告)Nomura International plc 171,481株(0.93%)-0.09% |
| 07/27 | (空売り報告)Barclays Capital Securities Ltd 525,900株(2.85%)-0.25% |
| 07/24 | 146 | 146 | 142 | 143 | -2.72% | 281,100 | - | -7.74% |
| 07/24 | (空売り報告)Barclays Capital Securities Ltd 571,600株(3.1%)+0.35% |
| 07/23 | 147 | 150 | 146 | 147 | -0.68% | 136,800 | - | -5.16% |
| 07/23 | (空売り報告)Nomura International plc 188,236株(1.02%)-0.11% |
| 07/23 | (空売り報告)Barclays Capital Securities Ltd 507,300株(2.75%)+0.09% |
| 07/22 | 151 | 151 | 147 | 148 | -1.99% | 142,000 | - | -4.52% |
| 07/22 | (空売り報告)Barclays Capital Securities Ltd 491,200株(2.66%)+0.11% |
| 07/21 | 149 | 153 | 148 | 151 | +1.34% | 356,600 | - | -2.58% |
| 07/21 | (空売り報告)Nomura International plc 209,995株(1.13%)-0.23% |
| 07/21 | (空売り報告)Barclays Capital Securities Ltd 470,800株(2.55%)+0.08% |
| 07/17 | 155 | 155 | 145 | 149 | -5.7% | 479,400 | - | -3.87% |
| 07/17 | (空売り報告)Barclays Capital Securities Ltd 455,800株(2.47%)-0.14% |
| 07/16 | 160 | 165 | 157 | 158 | -1.25% | 205,700 | - | +2.6% |
| 07/16 | (空売り報告)Barclays Capital Securities Ltd 482,200株(2.61%)+0.21% |
| 07/15 | 155 | 160 | 155 | 160 | +2.56% | 128,900 | - | +3.9% |
| 07/15 | (空売り報告)Barclays Capital Securities Ltd 443,200株(2.4%)+0.07% |
| 07/14 | 152 | 158 | 152 | 156 | +1.3% | 117,400 | - | +1.3% |
| 07/14 | (空売り報告)Nomura International plc 252,456株(1.36%)-0.09% |
| 07/13 | 156 | 162 | 153 | 154 | -2.53% | 255,800 | - | +0.65% |
| 07/13 | (空売り報告)Nomura International plc 267,465株(1.45%)+0.16% |
| 07/13 | (空売り報告)Barclays Capital Securities Ltd 430,200株(2.33%)+0.1% |
| 07/10 | 149 | 158 | 149 | 158 | +5.33% | 291,400 | - | +3.27% |
| 07/10 | (空売り報告)GOLDMAN SACHS JAPAN CO., LTD. 89,800株(0.48%)-0.13%義務消失 |
| 07/10 | (空売り報告)Nomura International plc 238,562株(1.29%)-0.37% |
| 07/10 | (空売り報告)MERRILL LYNCH INTERNATIONAL 78,400株(0.46%)-0.07%義務消失 |
| 07/10 | (空売り報告)Barclays Capital Securities Ltd 411,600株(2.23%)+0.1% |
| 07/09 | 151 | 152 | 147 | 150 | +0.67% | 120,800 | - | -1.96% |
| 07/09 | (空売り報告)Nomura International plc 306,334株(1.66%)-0.05% |
| 07/09 | (空売り報告)MERRILL LYNCH INTERNATIONAL 90,400株(0.53%)-0.03% |
| 07/08 | 154 | 154 | 148 | 149 | -3.87% | 443,700 | - | -2.61% |
| 07/08 | (空売り報告)Nomura International plc 315,824株(1.71%)+0.18% |
| 07/08 | (空売り報告)MERRILL LYNCH INTERNATIONAL 96,500株(0.56%)再IN |
| 07/08 | (空売り報告)Barclays Capital Securities Ltd 394,100株(2.13%)+0.16% |
| 07/07 | 160 | 161 | 153 | 155 | -2.52% | 236,200 | - | +1.31% |
| 07/07 | (空売り報告)MERRILL LYNCH INTERNATIONAL 82,500株(0.48%)-0.04%義務消失 |
| 07/07 | (空売り報告)Barclays Capital Securities Ltd 363,200株(1.97%)+0.15% |
| 07/06 | (IR情報)17:00 個人投資家様向けIR説明会アーカイブ配信のお知らせ |
| 07/06 | 156 | 163 | 155 | 159 | +3.25% | 478,600 | - | +3.92% |
| 07/06 | (空売り報告)JPM Securities Japan Co Ltd. 82,000株(0.44%)-0.08%義務消失 |
| 07/06 | (空売り報告)Nomura International plc 282,247株(1.53%)-0.39% |
| 07/06 | (空売り報告)MERRILL LYNCH INTERNATIONAL 89,300株(0.52%)再IN |
| 07/06 | (空売り報告)Barclays Capital Securities Ltd 336,100株(1.82%)+0.08% |
| 07/03 | (5%ルール)マッコーリーバンクリミテッド(Macquarie Bank Li…(0.63%) |
| 07/03 | (IR情報)9:30 PPMX-T003:多血症治療薬としての用途特許の米国における特許査定のお知らせ |
| 07/03 | 154 | 156 | 147 | 154 | -1.28% | 1,139,600 | - | +1.32% |
| 07/03 | (空売り報告)Nomura International plc 354,709株(1.92%)+0.21% |
| 07/03 | (空売り報告)Barclays Capital Securities Ltd 321,400株(1.74%)-0.42% |
| 07/03 | (空売り報告)GOLDMAN SACHS INTERNATIONAL 74,366株(0.4%)-0.16%義務消失 |
| 07/02 | 166 | 176 | 154 | 156 | -4.88% | 1,533,800 | - | +2.63% |
| 07/02 | (空売り報告)Nomura International plc 316,871株(1.71%)+0.14% |
| 07/02 | (空売り報告)GOLDMAN SACHS INTERNATIONAL 103,666株(0.56%)-0.06% |
| 07/01 | (IR情報)15:30 PPMX-T003:真性多血症の第I相臨床試験参加者を対象とした臨床研究の結果について |
| 07/01 | 160 | 164 | 150 | 164 | +3.14% | 765,200 | - | +7.19% |
| 07/01 | (空売り報告)Nomura International plc 290,966株(1.57%)-0.38% |
| 07/01 | (空売り報告)MERRILL LYNCH INTERNATIONAL 75,200株(0.44%)-0.06%義務消失 |
| 07/01 | (空売り報告)Barclays Capital Securities Ltd 398,300株(2.16%)-0.07% |
| 07/01 | (空売り報告)GOLDMAN SACHS INTERNATIONAL 114,466株(0.62%)-0.19% |
| 06/30 | (IR情報)16:00 (訂正)「事業計画及び成長可能性に関する事項」の一部訂正について |
| 06/30 | 164 | 165 | 157 | 159 | -3.05% | 625,600 | - | +3.92% |
| 06/30 | (空売り報告)GOLDMAN SACHS JAPAN CO., LTD. 112,500株(0.61%)新規 |
| 06/30 | (空売り報告)JPM Securities Japan Co Ltd. 96,900株(0.52%)-0.2% |
| 06/30 | (空売り報告)Nomura International plc 360,764株(1.95%)+0.16% |
| 06/30 | (空売り報告)MERRILL LYNCH INTERNATIONAL 86,400株(0.5%)-0.14% |
| 06/30 | (空売り報告)GOLDMAN SACHS INTERNATIONAL 150,966株(0.81%)+0.07% |
| 06/29 | 167 | 168 | 160 | 164 | 0% | 730,700 | - | +7.19% |
| 06/29 | (空売り報告)JPM Securities Japan Co Ltd. 133,400株(0.72%)-0.15% |
| 06/29 | (空売り報告)MERRILL LYNCH INTERNATIONAL 110,300株(0.64%)-0.42% |
| 06/29 | (空売り報告)Barclays Capital Securities Ltd 412,800株(2.23%)+0.27% |
| 06/26 | 162 | 171 | 159 | 164 | -3.53% | 1,294,800 | - | +7.19% |
| 06/26 | (空売り報告)Nomura International plc 330,623株(1.79%)-0.37% |
| 06/26 | (空売り報告)MERRILL LYNCH INTERNATIONAL 181,200株(1.06%)-0.07% |
| 06/26 | (空売り報告)GOLDMAN SACHS INTERNATIONAL 137,366株(0.74%)+0.11% |
| 06/25 | (IR情報)15:30 行使価額修正条項付新株予約権の大量行使、行使完了及び月間行使状況に関するお知らせ |
| 06/25 | (IR情報)15:30 事業計画及び成長可能性に関する事項 |
| 06/25 | 168 | 194 | 159 | 170 | +7.59% | 9,177,400 | - | +11.11% |
| 06/25 | (空売り報告)JPM Securities Japan Co Ltd. 161,100株(0.87%)+0.19% |
| 06/25 | (空売り報告)Nomura International plc 398,531株(2.16%)+0.29% |
| 06/25 | (空売り報告)MERRILL LYNCH INTERNATIONAL 192,600株(1.13%)+0.42% |
| 06/25 | (空売り報告)Barclays Capital Securities Ltd 361,700株(1.96%)+0.87% |
| 06/25 | (空売り報告)GOLDMAN SACHS INTERNATIONAL 116,266株(0.63%)再IN |
| 06/24 | (IR情報)18:00 行使価額修正条項付新株予約権の大量行使に関するお知らせ |
| 06/24 | 147 | 176 | 147 | 158 | +9.72% | 3,555,100 | - | +3.27% |
| 06/24 | (空売り報告)JPM Securities Japan Co Ltd. 119,400株(0.68%)再IN |
| 06/24 | (空売り報告)Nomura International plc 318,309株(1.87%)-0.13% |
| 06/24 | (空売り報告)MERRILL LYNCH INTERNATIONAL 120,900株(0.71%)再IN |
| 06/24 | (空売り報告)Barclays Capital Securities Ltd 185,600株(1.09%)-0.38% |
| 06/23 | (IR情報)11:00 EirGenix, Inc.と抗体医薬品に関する協業の検討に向けた覚書締結のお知らせ |
| 06/23 | 151 | 152 | 142 | 144 | -5.26% | 572,400 | - | -6.49% |
| 06/23 | (空売り報告)Nomura International plc 340,596株(2%)-0.17% |
| 06/22 | (IR情報)11:00 (訂正・数値データ訂正)「2026年3月期決算短信〔日本基準〕(非連結)」の一部訂正について |
| 06/22 | 150 | 156 | 149 | 152 | +3.4% | 271,800 | - | -1.94% |
| 06/22 | (空売り報告)Barclays Capital Securities Ltd 250,000株(1.47%)-0.04% |
| 06/19 | (空売り報告)Nomura International plc 370,379株(2.17%)-0.11% |
| 06/19 | (空売り報告)Barclays Capital Securities Ltd 257,000株(1.51%)+0.18% |
| 06/18 | (空売り報告)Barclays Capital Securities Ltd 226,900株(1.33%)+0.22% |
| 06/17 | (空売り報告)Barclays Capital Securities Ltd 189,100株(1.11%)+0.09% |
| 06/15 | (IR情報)15:30 名古屋大学との共同研究による特許取得のお知らせ |